Evidence map›Paper›PMID 26620556›Full record

ArticleThe Journal of biological chemistry2016

Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities.

Sriram Ambadapadi, Ganesh Munuswamy-Ramanujam, Donghang Zheng, Colin Sullivan, Erbin Dai, Sufi Morshed, Baron McFadden, Emily Feldman, Melissa Pinard, Robert McKenna and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Neuroserpin: structure, function, physiology and pathology.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Therapeutic SERPINs: Improving on Nature.Frontiers in cardiovascular medicine · 2021
    Review
  12. Review
  13. RecombinantPharmaceutics · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. American journal of physiology. Gastrointestinal and liver physiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Sriram AmbadapadiFrom the Division of Cardiovascular Medicine, Department of Medicine, and.
Ganesh Munuswamy-RamanujamFrom the Division of Cardiovascular Medicine, Department of Medicine, and the Interdisciplinary Institute of the Indian System of Medicine, SRM University, Kattankulathur, Tamil Nadu 603203, India.
Donghang ZhengFrom the Division of Cardiovascular Medicine, Department of Medicine, and.
Colin SullivanFrom the Division of Cardiovascular Medicine, Department of Medicine, and.
Erbin DaiFrom the Division of Cardiovascular Medicine, Department of Medicine, and.
Sufi MorshedFrom the Division of Cardiovascular Medicine, Department of Medicine, and.
Baron McFaddenthe Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32608 and.
Emily Feldmanthe Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32608 and.
Melissa Pinardthe Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32608 and.
Robert McKennathe Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32608 and.
Scott Tibbettsthe Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32608 and.
Alexandra LucasFrom the Division of Cardiovascular Medicine, Department of Medicine, and the Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32608 and Alexandra.lucas@medicine.ufl.edu.
University of Florida · USSRM Institute of Science and Technology · IN

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
BASIC MICROBIOLOGY &INFECTIOUS DISEASEST32AI007110 · NIAID · UNIVERSITY OF FLORIDA · PI Stephanie M Karst · 1985 to 2026
$4.3M
Manipulation of inflammasomes and NF-kB signaling in human myeloid cells by MyxomR01AI100987 · NIAID · UNIVERSITY OF FLORIDA · PI MCFADDEN, GRANT · 2013 to 2017
$1.9M
Serpin Modulation of Inflammatory Vasculitis; Potential for Immunomodulatory TherRC1HL100202 · NHLBI · UNIVERSITY OF FLORIDA · PI LUCAS, ALEXANDRA ROSE · 2009 to 2010
$1.0M
NCATS NIH HHS UL1 TR001427NHLBI NIH HHS 1RC1HL100202-01NHLBI NIH HHS RC1 HL100202NIAID NIH HHS 1 R01 AI100987-01A1NIAID NIH HHS R01 AI100987NIAID NIH HHS T32 AI007110
6 · The paper itself

Abstract

Serpins regulate coagulation and inflammation, binding serine proteases in suicide-inhibitory complexes. Target proteases cleave the serpin reactive center loop scissile P1-P1' bond, resulting in serpin-protease suicide-inhibitory complexes. This inhibition requires a near full-length serpin sequence. Myxomavirus Serp-1 inhibits thrombolytic and thrombotic proteases, whereas mammalian neuroserpin (NSP) inhibits only thrombolytic proteases. Both serpins markedly reduce arterial inflammation and plaque in rodent models after single dose infusion. In contrast, Serp-1 but not NSP improves survival in a lethal murine gammaherpesvirus68 (MHV68) infection in interferon γ-receptor-deficient mice (IFNγR(-/-)). Serp-1 has also been successfully tested in a Phase 2a clinical trial. We postulated that proteolytic cleavage of the reactive center loop produces active peptide derivatives with expanded function. Eight peptides encompassing predicted protease cleavage sites for Serp-1 and NSP were synthesized and tested for inhibitory function in vitro and in vivo. In engrafted aorta, selected peptides containing Arg or Arg-Asn, not Arg-Met, with a 0 or +1 charge, significantly reduced plaque. Conversely, S-6 a hydrophobic peptide of NSP, lacking Arg or Arg-Asn with -4 charge, induced early thrombosis and mortality. S-1 and S-6 also significantly reduced CD11b(+) monocyte counts in mouse splenocytes. S-1 peptide had increased efficacy in plasminogen activator inhibitor-1 serpin-deficient transplants. Plaque reduction correlated with mononuclear cell activation. In a separate study, Serp-1 peptide S-7 improved survival in the MHV68 vasculitis model, whereas an inverse S-7 peptide was inactive. Reactive center peptides derived from Serp-1 and NSP with suitable charge and hydrophobicity have the potential to extend immunomodulatory functions of serpins.

Indexed as

Immunologic FactorsMembrane ProteinsPeptidesAnimalsBlood CoagulationDisease Models, AnimalHerpesviridae InfectionsHumansJurkat CellsMiceMice, KnockoutRhadinovirusVasculitisImmunologic FactorsMembrane ProteinsPeptidesSerp1 protein, mousearteryherpesvirusinflammationmonocytepeptidespox virusesreactive center loopserpin

Identifiers

PMID26620556
PMCPMC4742751
OpenAlexW2182303898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.